MusclePharm Corporation (MSLP) a une note globale de santé financière de B avec un score composite de 0 sur 5.
Cela suggère que l'entreprise fait face à des défis financiers à surveiller. Note au 2023-01-24.
| Date | Note | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2023-01-24 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-01-20 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-01-19 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-01-17 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-01-13 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-01-12 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-01-11 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-01-10 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-01-09 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-01-06 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-01-05 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-01-03 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
